Large Cap - Spark Newswire

1 minute read

Medtronic Scores CE Mark For Extravascular Defibrillator System For Abnormal Heart Rhythms

Today, 12:06 PM

The European authority has approved Medtronic plc’s (NYSE:MDT) Aurora EV-ICD MRI SureScan (Extravascular Implantable Cardioverter-Defibrillator) and Epsila EV MRI SureScan defibrillation…

MDT

1 minute read

Stryker’s Q Guidance System Scores FDA Clearance For Cranial Applications

By Vandana Singh

Today, 12:06 PM

Stryker Corporation (NYSE:SYK) announced that its Q Guidance System with Cranial Guidance Software received FDA510(k) clearance. The Q Guidance System…

SYK

1 minute read

Shockwave Medical Shares Gain As Q4 Earnings Surpass Wall Street Expectations

By Vandana Singh

Today, 12:06 PM

Shockwave Medical Inc (NASDAQ:SWAV) reported Q4 FY22 revenue of $144 million, an increase of 71% year-over-year, beating the consensus of…

SWAV

2 minute read

Analysts Weigh In On Applied Materials Earnings Print: What Investors Need To Know

By AJ Fabino

Today, 12:06 PM

Semiconductor equipment provider Applied Materials, Inc (NASDAQ: AMAT) beat the Street's expectations for its fiscal first quarter. The Santa Clara, California-based company issued upbeat guidance for the current quarter. As a result, several prominent analysts issued notes on the stock.

AMAT

1 minute read

Pfizer, Valneva Discontinue Certain Trial Sites For Phase 3 Study Of Lyme Disease Vaccine Candidate

By Vandana Singh

Today, 12:06 PM

Pfizer Inc (NYSE:PFE) and Valneva SE (NASDAQ:VALN) announce that Pfizer, as the study sponsor, will discontinue a significant percentage of participants in the…

PFE

1 minute read

Merck Says Keytruda/Chemo Combo Improved Overall Survival Compared To Chemo Alone In Gastric Cancer Settings

By Vandana Singh

Today, 12:06 PM

Merck & Co Inc (NYSE:MRK) announced results from the pivotal Phase 3 KEYNOTE-859 trial of Keytruda (pembrolizumab) with fluoropyrimidine- and platinum-containing…

MRK

1 minute read

Pfizer Releases Interim Update On PARP Inhibitor Combo Therapy For Prostate Cancer, Secures FDA Priority Review

By Vandana Singh

Today, 12:06 PM

Pfizer Inc (NYSE:PFE) announced results from the Phase 3 TALAPRO-2 study of Talzenna (talazoparib) in combination with Xtandi (enzalutamide) in 1,106…

PFE

1 minute read

Analyst Views West Pharmaceutical’s Q4 Earnings Impressive Despite Headwinds

By Vandana Singh

Today, 12:06 PM

West Pharmaceutical Services Inc (NYSE:WST) reported Q4 2022 net sales of $708.7 million, down 3%, and organic net sales growth…

WST

1 minute read

YouTube CEO Susan Wojcicki Steps Down, Says ‘Time Is Right For Me’

By Vandana Singh

Today, 12:06 PM

On Thursday, Alphabet Inc's (NASDAQ: GOOG) (NASDAQ: GOOGL) YouTube CEO Susan Wojcicki said that she's stepping down. Chief product officer Neal Mohan will lead as the SVP and new head of YouTube.

GOOG

2 minute read

Analysts Are Bullish On Seagen’s Catalyst-Rich Pipeline, Finding No Problem With No M&A

By Vandana Singh

Today, 12:06 PM

Seagen Inc (NASDAQ:SGEN) reported a Q4 EPS loss of $(0.80), better than the consensus of $(1.05) and $(0.95) a year…

SGEN